{"anticipatedPostingDate":"2026-10","denomUnitsSelected":"Participants","reportingStatus":"NOT_POSTED","timeFrame":"Parts 1 and 2: Till study completion approximately 3 years 7 months","title":"Pre- and Post-dose Concentrations of Elranatamab: Parts 1 and 2","type":"SECONDARY"}